The influence of Helicobacter pylori eradication on the gastric mucosal content of epidermal growth factor, transforming growth factor-alpha, and their common receptor. 1998

F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
Laboratory of Biochemistry, IRCCS Saverio de Bellis, Castellana G. (Bari), Italy.

BACKGROUND The relationship between the expression of epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) and that of their receptor (EGF-R) in the Helicobacter pylori-infected gastric mucosa has not been completely elucidated. The aim of this study was to examine the interplay between H. pylori colonization and gastric mucosal growth factor content. METHODS By means of a solid-phase enzyme-linked immunosorbent assay EGF, TGF-alpha, and EGF-R levels and interleukin-1beta (IL-1beta) content, which is considered a marker of chronic inflammation, were evaluated in the antral mucosa of 24 H. pylori-positive patients before and 8 weeks after eradication therapy. RESULTS After therapy H. pylori was eradicated in 19 patients. The eradication was accompanied by a significant decrease in IL-1beta content and an increase in EGF and TGF-alpha levels. On the other hand, in the five patients in whom the bacterium was not eradicated EGF, TGF-alpha, and EGF-R levels were quite similar to those assayed before therapy, whereas IL-1beta content was still high. CONCLUSIONS These results suggest that H. pylori exerts an inhibitory effect on the mucosal expression of EGF and TGF-alpha, which are likely involved in the gastric mucosa repair process.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004415 Dyspepsia Impaired digestion, especially after eating. Indigestion,Dyspepsias,Indigestions
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer

Related Publications

F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
October 1999, The American journal of gastroenterology,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
November 1993, The Clinical investigator,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
May 2000, American journal of physiology. Gastrointestinal and liver physiology,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
February 1998, Scandinavian journal of gastroenterology,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
November 1996, Digestive diseases and sciences,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
August 1992, Scandinavian journal of gastroenterology,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
March 1995, The Journal of clinical endocrinology and metabolism,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
October 1991, Biochemistry international,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
March 2001, Journal of gastroenterology and hepatology,
F Russo, and C Messa, and L Amati, and L Caradonna, and C Leoci, and G Di Matteo, and E Jirillo, and A Di Leo
October 1995, European journal of gastroenterology & hepatology,
Copied contents to your clipboard!